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Introduction {#sec1}
============

Fragile X syndrome (FXS) is the leading single gene cause of intellectual disability, with co-occurring autism, hyperactivity, and epilepsy ([@bib33]). FXS results from hypermethylation of the *FMR1* gene and loss of the protein FMRP. Rodent models of FXS have revealed a role for FMRP in directly and indirectly regulating cellular and local circuit excitability ([@bib18]; [@bib27]; [@bib81]). They also display behavioral phenotypes, such as increased susceptibility to audiogenic seizures that have been linked to cellular/circuit hyperexcitability ([@bib23]; [@bib57]; [@bib61]). Furthermore, it has been suggested that impairments in learning and memory may result, in part, from these alterations in cellular excitability ([@bib18]).

Cellular excitability is tightly regulated by, for example, intrinsic mechanisms such as ion channel density and function, synaptic mechanisms that regulate the balance of excitation to inhibition (E:I balance), and the regulation of action potential (AP) initiation at the axon initial segment (AIS). FMRP has been shown to directly regulate excitability through direct FMRP-ion channel interactions ([@bib21]; [@bib22]). The loss of FMRP also potentially alters the translational regulation, and hence the density and/or activity-dependent expression of ion channels and synaptic proteins critical for regulating excitability ([@bib2]; [@bib8]; [@bib9]; [@bib13]; [@bib14]; [@bib27]). However, changes in cellular excitability may not be a direct consequence of the loss of FMRP; rather, excitability phenotypes may arise as a compensatory or homeostatic change to try to normalize neuronal excitability following altered FMRP-dependent events. Recent findings indicate that the altered E:I balance observed in the mouse model of FXS serves to normalize neuronal excitability in the primary somatosensory cortex ([@bib2]; [@bib24]).

The AIS plays a key role in regulating neuronal excitability. The AIS originates from the soma or proximal dendrite ([@bib72]), where it is required for the correct integration and dynamic control of AP generation ([@bib46]). Although axonal APs can still be evoked when the AIS is dissolved ([@bib82]), spontaneously generated APs are abolished, and the waveform of the AP is altered. The AIS is composed of specific cytoskeletal elements (i.e., ankyrin G and β4-spectrin) and a high density of voltage-gated sodium channels (VSGCs; [@bib46]; [@bib60]). The AIS is not static, but can regulate its length and position in response to changing neuronal activity states ([@bib28]; [@bib29]; [@bib30]; [@bib44]). Hence, it can act as a means of homeostatic regulation the neuron AP discharge in response to changing activity levels. For example, in cultured dentate granule cells, the AIS shortens in length following prolonged depolarization ([@bib29]), while *in vivo*, the AIS has been suggested to increase in length following prolonged sensory deprivation, and modulate VGSC density ([@bib30]; [@bib43]; [@bib44]). However, these homeostatic alterations to AIS length and function require long-term alteration in neuronal activity, which at present have not been observed in CA1 of the hippocampus ([@bib40]).

Despite playing a key role in regulating cellular excitability, the AIS has received little attention in FXS, or in developmental disorders more generally. A notable exception is an increase in AIS length observed in the Angelman syndrome model of intellectual disability ([@bib39]), which shares some excitability features with FXS, as well as a variety of epilepsy mouse models also displaying AIS-dependent phenotypes ([@bib77]). Here, we directly examine whether the AIS is altered in a mouse model of FXS. We focus on pyramidal cells of the hippocampal area CA1, due to emerging evidence for enhanced cellular excitability of these neurons in *Fmr1*^−*/y*^ mice ([@bib48]; [@bib71]). The present study combines immunohistological labeling, whole-cell patch-clamp recordings, and live 2-photon imaging to test the hypothesis that AIS pathology contributes to the excitability phenotypes of *Fmr1*^−*/y*^ mice.

Results {#sec2}
=======

CA1 PCs Are Hyperexcitable in the *Fmr1*^*−/y*^ Mouse, Resulting from Increased AIS Lengths {#sec2.1}
-------------------------------------------------------------------------------------------

To assess the excitability of CA1 pyramidal cells (PCs) we performed whole-cell patch-clamp recordings from acute hippocampal slices of postnatal (P) days 28--35 wild-type (WT) and *Fmr1*^−/y^ littermate mice. We measured the active properties of CA1 PCs in response to small depolarizing steps (25 pA, 500 ms), all from a holding potential of −70 mV to induce well-controlled AP discharge ([Figure 1](#fig1){ref-type="fig"}A). Analysis of AP discharge revealed a leftward shift in the current-frequency response in *Fmr1*^*−*/y^ mice compared to that in WT mice ([Figure 1](#fig1){ref-type="fig"}B). WT CA1 PCs (33 cells from 15 mice) reliably produced APs with a rheobase current of 156.8 ± 11.6 pA, with a voltage threshold of −42.6 ± 0.6 mV, and peak AP discharge of 36.2 ± 1.1 Hz. In *Fmr1*^*−*/y^ littermates (29 cells from 14 mice), we observed a significantly lower rheobase current of 111.7 ± 10.8 pA (χ^2^~(df60)~ = 16.6, p = 4.6 × 10^−5^, generalized form of the linear mixed-effects model \[GLMM\]), resulting from a more hyperpolarized voltage threshold of −45.9 ± 1.1 mV (χ^2^~(df60)~ = 13.5, p = 0.0002, GLMM). The maximum firing of *Fmr1*^−/y^ neurons was 38.9 ± 1.0 Hz, not significantly higher than WT (t~(11,8)~ = 1.53, p = 0.50, Holm-Sidak test). To confirm that this hyperexcitability was due to an altered voltage threshold, we measured passive membrane properties in *Fmr1*^−/y^ and WT mice. CA1 PCs from WT mice had a resting membrane potential of −60.2 ± 1.4 mV and, in response to small, hyperpolarizing steps (−10 pA, 500 ms), an input resistance of 162.1 ± 14.2 MΩ. In *Fmr1*^*−*/y^ mice, the input resistance was not different from that of WT mice (169.4 ± 10.6 MΩ, χ^2^~(df60)~ = 0.81, p = 0.37, GLMM); however, the resting membrane potential was substantially more hyperpolarized (−64.2 ± 1.9 mV, χ^2^~(df60)~ = 8.9, p = 0.003, GLMM). We observed no difference in AP kinetic properties, such as amplitude, half-height duration, or maximum rates of rise or decay, which are detailed in [Table S1](#mmc1){ref-type="supplementary-material"}. Furthermore, a full summary of all of the statistical tests performed in the present study is provided in [Table S2](#mmc2){ref-type="supplementary-material"}. These data show that CA1 PCs in *Fmr1*^−/y^ mice appear hyperexcitable due to a reduced threshold for AP discharge.Figure 1Increased CA1 PC Excitability and AIS Length in *Fmr1*^−/y^ Mice(A) Representative voltage responses from WT (black) and *Fmr1*^−*/y*^ mice (red), in response to depolarizing current steps (0--400 pA, 25 pA steps, 500 ms duration).(B) Current frequency plot for WT mice (33 cells from 15 mice) and *Fmr1*^−*/y*^ mice (29 cells from 14 mice), indicating increased AP discharge.(C--F) Quantification of (C) rheobase, (D) voltage threshold, (E) resting membrane potential, and (F) input resistance from both genotypes.(G) Top: overview flattened confocal stacks of CA1 labeled for ankyrinG (green pseudocolor) and NeuN (blue pseudocolor). Bottom: high-power magnification of a single AIS. The AIS total extent is indicated (dashed line). Scale bars (top): 20 μm, (bottom): 5 μm.(H) Average cumulative distributions (thick lines) of AIS lengths across all mice examined for each genotype. Cumulative distributions for individual mice shown below (thin lines).(I) Quantification of AIS length for each genotype (750 AIS from 8 WT mice, 896 AIS from 9 *Fmr1*^−/y^ mice). All bar chart data are overlain by the averages of individual mice, with the total mice analyzed in parentheses.ns, p \> 0.05, ^∗^p \< 0.05 from 2-way RM ANOVA (B) and GLMM (C--I). All of the data are shown as means ± SEMs.

The presence of a high density of sodium channels at the AIS, and its role in controlling the voltage threshold ([@bib42]) led us to ask whether the AIS was structurally altered in the FXS mouse model, as in the Angelman syndrome mouse model ([@bib39]). Immunohistochemical labeling was performed on hippocampal sections from perfusion-fixed mice using ankyrinG, a specific AIS marker ([Figure 1](#fig1){ref-type="fig"}G). AnkyrinG reliably labeled AISs emerging from the soma (∼80% of AISs) or a proximal dendrite (∼20% of AISs), which entered the *Stratum oriens* (*str. oriens)* of CA1. The average AIS length in WT mice was 25.9 ± 0.3 μm (750 AISs from 8 mice); meanwhile, *Fmr1*^−/y^ mice had AISs that on average were 20% longer, with an average length of 31.0 ± 0.3 μm (896 AISs from 9 mice; t-ratio~(df10)~ = −3.67, p = 0.0046, GLMM; [Figures 1](#fig1){ref-type="fig"}H and 1I). We confirmed that the number of AISs measured per mouse was sufficient to define the difference we observed using bootstrapping analysis ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). We observed similar distances from the soma for AISs measured in *Fmr1*^−/y^ CA1 PCs (2.7 ± 0.2 μm from soma) as compared to WT (3.2 ± 0.2 μm, p = 0.30, LMM; [Figure S1](#mmc1){ref-type="supplementary-material"}C). To determine whether these effects on AIS length were specific to the CA1 or were more widespread across the brain, we next assessed the AIS length in the medial prefrontal cortex (mPFC) and hippocampal subfield CA3 ([Figures S1](#mmc1){ref-type="supplementary-material"}E--S1H). In both areas tested, the AIS length was longer in *Fmr1*^−/y^ mice, with 12% and 11% longer AISs from layer 5 (L5) mPFC and CA3, respectively. Analysis of the intrinsic excitability of L5 mPFC PCs revealed that while these neurons showed increased excitability, this was not associated with any change in voltage threshold or rheobase ([Figures S1](#mmc1){ref-type="supplementary-material"}I--S1K). These data suggest that while AIS length may be longer in these other brain areas, it is does not contribute to large physiological changes.

As many factors contribute to the overall excitability of a given neuron, we next asked whether this change in AIS length was sufficient to account for the altered voltage threshold. To address this, we produced a single-cell computational model of a CA1 PC based on realistic constraints ([@bib55]) and altered AIS length, assuming no change in sodium-channel density ([Figure S2](#mmc1){ref-type="supplementary-material"}). Under these conditions, only changing the AIS length results in near-identical changes in voltage threshold and rheobase, without affecting the maximum discharge rate. These data reveal an increase in CA1 PC excitability, primarily due to a voltage threshold change. Furthermore, the region-specific increase in AIS length observed in *Fmr1*^−/y^ mice is sufficient to account for the altered excitability.

CA1 PCs in Acute Hippocampal Slices Display Activity-Dependent Excitability Changes, Which Is Enhanced in *Fmr1*^*−/y*^ Mice {#sec2.2}
----------------------------------------------------------------------------------------------------------------------------

A key feature of neuronal excitability is its ability to self-modulate in the face of sustained alterations to ongoing activity ([@bib53]). The ability of neurons to undergo such homeostatic regulation has been shown to be enhanced in the mouse model of FXS, albeit in cultured neurons ([@bib13]). Therefore, we next asked whether the enhanced excitability we observe in *Fmr1*^−/y^ mice results from underlying changes in cell homeostasis, leading to the inappropriate regulation of cell function, using a paradigm previously reported to depolarize neurons over short ([@bib25]; [@bib29]) and long ([@bib28]; [@bib58]) timescales *in vitro*. To directly assess the effect of depolarization in a cell-wise manner, we performed whole-cell patch-clamp recordings from the same CA1 PCs before and after 3-h application of 15 mM KCl, using 15 mM NaCl as an osmotic control. Cells were targeted by the inclusion of Alexa Fluor 488 (100 μM) in the patch pipette to allow recording from the same neuron and to examine intrinsic physiology at both time points ([Figures 2](#fig2){ref-type="fig"}A and 2B). From recordings of WT CA1 PCs, 3-h treatment with 15 mM NaCl did not alter the current-frequency relationship (t~1, 11~ = 0.51, p = 0.49, repeated-measures \[RM\] 2-way ANOVA; [Figure 2](#fig2){ref-type="fig"}C, left) or any other measure physiological property measured. By comparison, 3-h treatment with 15 mM KCl resulted in a small but significant decrease in AP discharge in WT CA1 PCs (t~1,\ 18~ = 6.37, p = 0.02, RM 2-way ANOVA; [Figure 2](#fig2){ref-type="fig"}C, right), consistent with previous reports ([@bib25]; [@bib58]). This change in AP discharge was paired with a 39% increase in the rheobase current from 159 ± 13 pA under control to 221 ± 24 pA after KCl (p = 0.002, LMM; [Figure 2](#fig2){ref-type="fig"}E) and a 23% reduction in input resistance (p = 0.05, LMM), as well as altered K^+^ channel function, as the AP decay rate was slowed by 14% (p = 0.05, LMM). However, we observed no change in voltage threshold (2% depolarized, p = 0.91, LMM; [Figure 2](#fig2){ref-type="fig"}F). These findings suggest that AIS structure may be unrelated to the observed physiological changes following such treatment in *ex vivo* brain tissue, which are likely due to multiple, complementary K^+^-channel mechanisms ([@bib41]; [@bib45]; [@bib58]).Figure 2Intrinsic Physiological Plasticity and Homeostatic Responses in WT and *Fmr1*^−/y^ Mice(A and B) Representative voltage responses from (A) WT (black) and (B) *Fmr1*^−/y^ (red) CA1 PCs to current injections, from −70 mV (0--400 pA, 25 pA steps, 500 ms duration).(C) Current frequency plots for the same CA1 PCs from WT mice, when recorded before (top) and after (bottom) 3-h NaCl (12 cells from 5 mice) or KCl (19 cells from 8 mice) applications.(D) According to the same format as (C), but for *Fmr1*^−/y^ mice (NaCl: 7 cells from 4 mice; KCl: 18 cells from 8 mice).(E and F) Pairwise analysis of rheobase current (E) and voltage threshold (F) from the same WT and *Fmr1*^−/y^ CA1 PCs.(G) Subtracted AP discharge across the range of injected currents given to CA1 PCs.ns, p \> 0.05, ^∗^p \< 0.05 from GLMM (E--G) and 2-way RM ANOVA (C, D, and H). All of the data are shown as means ± SEMs.

We next assessed the effect of sustained depolarization on the function of *Fmr1*^−/y^ CA1 PCs in acute brain slices. 15 mM of KCl also appeared to very strongly attenuate the current-frequency relationship in *Fmr1*^−/y^ mice (t~1,\ 17~ = 21.95, p = 0.0002, RM 2-way ANOVA; [Figures 2](#fig2){ref-type="fig"}B and 2D); 15 mM NaCl treatment for 3 h had no effect on AP discharge (t~1,\ 6~ = 0.14, p = 0.72, RM 2-way ANOVA; [Figure 2](#fig2){ref-type="fig"}D, left). Similar to observations from WT mice, we observed a 66% increase in rheobase from 113 ± 11 pA to 188 ± 18 pA; (p = 0.004, LMM; [Figure 2](#fig2){ref-type="fig"}E) and a tendency to decreased input resistance (−14%, 197 ± 22 MΩ to 167 ± 20 MΩ; p = 0.17, LMM). As for WT mice, we saw no change in voltage threshold following KCl treatment (p = 0.95, LMM; [Figure 2](#fig2){ref-type="fig"}F). We observed an 18% slowing of the AP decay rate (p = 0.008, GLMM), indicative of a potentially similar role of K^+^ channels in this physiological plasticity as in WT neurons. To allow us to compare the change in AP discharge between WT and *Fmr1*^−/y^ mice, we subtracted the number of APs produced following KCl application from the control measurement, as each current step tested ([Figure 2](#fig2){ref-type="fig"}G). We observed a much larger decrease in the number of APs elicited by *Fmr1*^−/y^ CA1 PCs, compared to WT (F~1,\ 35~ = 23.84, p \< 0.0001, 2-way ANOVA), which was most apparent over the range of 175--300 pA (interaction: F ~1, 35~ = 2.225, p = 0.0052; Bonferroni post-tests T~17,20~ = 3.0, 3.0, 3.2, 3.3, 3.3, 3.2; p = 0.05, 0.04, 0.03, 0.02, 0.02, 0.03) In no tested intrinsic parameter did we observe a change following the 3-h treatment with NaCl treatment. These data clearly show that responses to prolonged depolarization are present in both WT and *Fmr1*^−/y^ mice; however, the latter respond more strongly to depolarizing stimuli, leading to reduced AP generation.

Short-Term Depolarization Results in AIS Shortening in WT and *Fmr1*^*−/y*^ Cultured Neurons but Lengthening in Intact Tissue {#sec2.3}
-----------------------------------------------------------------------------------------------------------------------------

We show above that prolonged depolarization of neurons in *ex vivo* tissue leads to a reduction in cellular excitability. Previously, it was shown that the application of 15 mM KCl reduces AIS length, over short timescales in cultured dentate gyrus neurons ([@bib25]; [@bib29]). Therefore, we asked whether this form of plasticity was present in *Fmr1*^−/y^ CA1 neurons, perhaps accounting for the differences in AIS length, baseline excitability, and enhanced cellular responses observed.

To address this, we used the same 15 mM KCl or NaCl treatment as we used for the physiological manipulation ([Figure 2](#fig2){ref-type="fig"}), but in a subset of acute hippocampal slices. Following slicing and recovery, slices were transferred to chambers containing artificial cerebrospinal fluid (ACSF), treated for 3 h with 15 mM KCl or NaCl (as osmotic control) then fixed and immunolabeled for ankyrinG ([Figure 3](#fig3){ref-type="fig"}A). Following 15 mM KCl treatment of slices, we observed AIS lengths in WT mice of 28.7 ± 1.7 μm, which were 11% longer than that of 15 mM NaCl osmotic controls (25.8 ± 1.4 μm, p \< 0.001, GLMM; [Figure 3](#fig3){ref-type="fig"}B). In *Fmr1*^*−*/y^ slices, we also observed a similar increase in AIS length, with AIS lengths following 15 mM KCl treatment of 29.4 ± 1.9 μm, 11% longer than NaCl controls (26.6 ± 1.6 μm; p \< 0.001, GLMM; [Figure 2](#fig2){ref-type="fig"}I). We observed no change in AIS distance from the soma following the 3-h 15 mM KCl treatment, as compared to NaCl controls ([Figure S2](#mmc1){ref-type="supplementary-material"}B). These data clearly indicate that short-term structural AIS shortening in CA1 neurons, over the timescales as described previously in cultured dentate gyrus neurons, is absent from the intact tissue from WT and *Fmr1*^−/y^ mice. In 10-day-old mice, we observed a very small shortening of the AIS in WT mice after 3 h KCl, which was not present in *Fmr1*^−/y^ neurons ([Figure S3](#mmc1){ref-type="supplementary-material"}).Figure 3Short-Term AIS Shortening Is Absent in Acute Slices after Sustained Depolarization(A) Representative flattened confocal stack of AIS labeled in acute hippocampal slices from WT (top) and *Fmr1*^−/y^ mice (bottom), following 3-h incubation with 15 mM KCl (right) or NaCl osmotic controls (left). AISs were visualized with ankyrinG (green pseudocolor) and measured in neurons labeled with NeuN (blue pseudocolor). Scale bars: 20 μm.(B) Quantification of AIS length following 3-h application of 15 mM KCl, compared to NaCl osmotic controls in WT mice. Average AIS length of each mouse tested is shown overlaid.(C) The same analysis as in (B), but in *Fmr1*^−/y^ mice.(D) AIS measured in primary dissociated hippocampal cell cultures produced from WT (left) and *Fmr1*^−/y^ (right) mice following 3 h of 15 mM NaCl or KCl and labeled with ankyrinG (green) and NeuN (blue). Scale bars: 20 μm (top), 10 μm (bottom).(E) Quantification of AIS length under control conditions from WT (black) and *Fmr1*^−/y^ (red) single-mouse cultures. The average AIS length per mouse (from 2 coverslips) is shown overlain; the number of mice is indicated in parentheses.(F) AIS lengths plotted for WT mouse cultured neurons following 3 h of 15 mM KCl and NaCl.(G) AIS lengths of *Fmr1*^−/y^ neurons following 15 mM KCl and NaCl application.(H) Comparative difference in AIS length (KCl length − NaCl length), plotted for each mouse.ns, p \> 0.05, ^∗^p \< 0.05, from LMM (B--G) and Student's 2-tailed unpaired t test (H). All of the data are shown as means ± SEMs.

As this form of plasticity has only been previously reported in cell culture, we finally asked whether we could confirm that this form of plasticity was present in our hands and test whether *Fmr1*^−/y^ neurons are capable of shortening. To examine the AIS structure in dissociated hippocampal cultures of WT and *Fmr1*^−/y^ mice ([Figure 3](#fig3){ref-type="fig"}D), we fixed coverslips at day *in vitro* 10 (DIV10), before and after 15 mM KCl or NaCl treatment and then measured the AIS from ankyrinG labeling. In WT primary hippocampal neurons, the AIS had an average length of 29.9 ± 1.0 μm. Similar to observations in fixed brains, *Fmr1*^−/y^ neurons had AISs that on average were 7% longer than those of WT mice (32.1 ± 0.7 μm, p \< 0.001, LMM; [Figure 3](#fig3){ref-type="fig"}E), confirming that hippocampal cultures obey the same relationship as observed in *ex vivo* tissue. Following the 15 mM KCl addition to the culture medium for 3 h, the WT AIS length in 15 mM KCl was 28.1 ± 1.2 μm, which is 10% shorter than NaCl controls (31.1 ± 1.2 μm, p \< 0.001, LMM; [Figure 3](#fig3){ref-type="fig"}F). In *Fmr1*^−/y^ cultures, we observed similar AIS shortening, with 15 mM KCl (30.3 ± 0.8 μm) being 7% shorter than NaCl controls (32.7 ± 1.1 μm, p \< 0.001, LMM; [Figure 3](#fig3){ref-type="fig"}G). The degree of AIS shortening between KCl and NaCl was modest but similar for both WT and *Fmr1*^−/y^ mice (p = 0.41, T~(df29)~ = 0.82, 2-tailed Student's t test; [Figure 3](#fig3){ref-type="fig"}H). These data indicate that short-term structural AIS plasticity is present in cultured WT and *Fmr1*^−/y^ neurons, but that different or additional factors may regulate structural plasticity following sustained depolarization in hippocampal neurons, such as the presence of an intact extracellular matrix. Furthermore, these findings suggest a functional disconnect between AP discharge properties and AIS length following prolonged depolarization.

One limitation of the above data is that AIS lengths before and after plasticity induction are measured in fixed tissue from different slices, thus precluding the direct measurement of potential within-cell shortening of AIS. As such, we next asked whether the AIS length of individual CA1 PCs were plastic during the application of 15 mM KCl. To address this, we performed 2-photon live imaging of acute hippocampal slices from a new transgenic mouse expressing GFP fused to the sodium channel β1 subunit (β1-NaV-GFP) that reliably labelled the AIS ([Figures 4](#fig4){ref-type="fig"}A and 4B) and which faithfully reflected ankyrinG immunolabeling ([Figure S4](#mmc1){ref-type="supplementary-material"}). This transgenic mouse was crossed with the *Fmr1*^−/y^ mouse line and 2-photon z stacks of images containing *str. pyramidale*, and proximal *str. oriens* of CA1 were collected before and after a 3-h treatment with either 15 mM KCl or 15 mM NaCl; AIS lengths were then measured ([Figure 4](#fig4){ref-type="fig"}C). A comparison of the starting AIS length to the final length showed no difference between either 15 mM NaCl or 15 mM KCl in WT (F~1,\ 158~ = 0.62, p = 0.43, sum-of-least-squares F-test; [Figure 4](#fig4){ref-type="fig"}D) or *Fmr1*^−/y^ mice (F~1,\ 85~ = 1.63, p = 0.21, sum-of-least-squares F-test; [Figure 4](#fig4){ref-type="fig"}E). Comparing the AIS length change between treatments from live imaging in WT mice, we observed that 3-h 15 mM NaCl treatment produced an average of 1.6 ± 1.0 μm increases in length, which are not different from the 1.1 ± 1.0 μm increases in length produced by 15 mM KCl treatment (p = 0.67, LMM). NaCl application to brain slices from *Fmr1*^−/y^ mice produced a 1.6 ± 1.3 μm shortening of the AIS, which is not different from the 2.1 ± 2.0 μm shortening observed in KCl (p = 1.0, LMM). Finally, modeling AIS lengths over the ranges we measured from CA1 PCs reveals that AIS length has the ability to change both AP discharge threshold and rheobase in a non-linear manner. However, small changes in membrane resistance, such as those we observed following KCl treatment, may best describe the homeostatic changes in rheobase that we observed ([Figures S2](#mmc1){ref-type="supplementary-material"}H and S2I). These data further confirm that short-term, depolarization-induced AIS shortening is absent in the *ex vivo* tissue of CA1, even when measured at the single-cell level in real time.Figure 4Live Imaging of the AIS Fails to Reveal Short-Term Structural Plasticity(A) Low-power flattened confocal stack of CA1 of the hippocampus showing β1-NaV-GFP (β1-GFP, green pseudocolor) expression compared to ankyrinG (red pseudocolor), showing an overlapping distribution. Scale bar: 100 μm.(B) High magnification of a β1-NaV-GFP labeled PC and AIS, demonstrating faithful overlap of GFP with ankyrinG labeling. Scale bar: 20 μm.(C) Representative 2-photon images of CA1 showing β1-NaV-GFP labeling under control conditions (0 h) compared to 3 h of treatment with 15 mM NaCl (top) or KCl (bottom). Scale bar: 10 μm.(D) Comparison of AIS length before (x axis) to the AIS length 3 h later for 15 mM NaCl (filled circles) and 15 mM KCl (open circles) in WT CA1 PCs. Data are shown for 99 AISs treated with NaCl and 65 AISs treated with KCl from 7 WT mice and fitted with linear regression (solid line, NaCl; dashed line, KCl).(E) The same data as in (D), but plotted for 44 AISs treated with NaCl and 45 AISs treated with KCl from 5 *Fmr1*^−/y^ mice.All of the data are shown as individual cell replicates with, where appropriate, fitted linear relationships.

Reduced Temporoammonic (TA) Input to CA1 Accounts for Homeostatic Changes to PCs {#sec2.4}
--------------------------------------------------------------------------------

The data we have presented so far show that CA1 PCs in *Fmr1*^−/y^ mice are hyperexcitable due to increased AP discharge related to increased AIS length and greater short-term adaptation of membrane excitability. These observations could reflect homeostatic remodeling of CA1 PCs in the *Fmr1*^−/y^ mouse, in response to reduced excitatory tone. To determine whether extrinsic TA input to CA1 is reduced in *Fmr1*^−/y^ mice, we performed correlated extracellular field and whole-cell patch-clamp recordings from CA1, combined with electrical stimulation of the TA afferents. Brief trains of electrical stimuli (5 stimuli at 20 Hz, 200 μs stimulus duration) were delivered via a bipolar, twisted NiChrome wire placed in distal *str. lacunosum-moleculare* ∼1 mm distal to CA1. Input-output relationships were recorded as both somatic whole-cell excitatory postsynaptic potentials (EPSP) or field EPSPs (fEPSPs; [Figure 5](#fig5){ref-type="fig"}A) from *str. lacunosum-moleculare* of CA1. To first assess the degree of TA afferent recruitment, we measured the afferent fiber volley from fEPSP recordings. We observed that increasing constant voltage stimuli resulted in a linearly increasing fiber volley. The relative recruitment of the fiber volley was similar in *Fmr1*^−/y^ slices, when compared to WT (F~1,\ 348~ = 2.12, p = 0.15, sum-of-least-squares F-test), suggesting the equivalent recruitment of entorhinal afferents, as previously described ([@bib75]). To determine whether synaptic responses from the TA pathway were altered, we measured both the dendritic field and somatic whole-cell responses, measured as a function of fiber volley amplitude ([Figure 5](#fig5){ref-type="fig"}B). Despite unchanged fiber volley amplitudes, the input-output response for fEPSPs in *Fmr1*^−/y^ brain slices was significantly reduced compared to WT in both peak amplitude (F~1,\ 348~ = 33.7, p \< 0.0001, sum-of-least-squares F-test) and area under the curve (F~1,\ 303~ = 32.1, p \< 0.0001, sum-of-least-squares F-test). Consistent with this observation, whole-cell EPSPs also showed lower input-output relationships (F~1,\ 346~ = 5.55, p = 0.019, sum-of-least-squares F-test; [Figure 5](#fig5){ref-type="fig"}G), indicating that dendritic filtering is insufficient to overcome reduced synaptic inputs ([@bib9]). As synaptic inhibition and excitation is known to be altered at TA inputs ([@bib75]), we next asked whether altered inhibition was the cause of the reduced input. Blocking GABA~A~ receptor-mediated inhibition with picrotoxin was also insufficient to overcome reduced dendritic inputs in *Fmr1*^−/y^ mice both in fEPSP recordings (F~1,\ 370~ = 23.6, p \< 0.0001, sum-of-least-squares F-test; [Figure 4](#fig4){ref-type="fig"}F) and whole-cell EPSPs (F~1,\ 324~ = 21.8, p \< 0.0001, sum-of-least-squares F-test; [Figure 4](#fig4){ref-type="fig"}H). Comparing the slopes of individual CA1 PC input-output plots, *Fmr1*^−/y^ cells had lower EPSP recruitment under both control (t~30~ = 3.21, p = 0.039, LMM; [Figure 4](#fig4){ref-type="fig"}I) and in the presence of picrotoxin (t~30~ = 3.21, p = 0.039, LMM; [Figure 4](#fig4){ref-type="fig"}I). These data show that TA inputs to the CA1 region of the hippocampus are reduced in strength, providing a plausible explanation for the homeostatic compensation of CA1 PC intrinsic physiology and AIS structure during postnatal development. To test whether the changes in excitability may represent a homeostatic compensation for the decrease in synaptic input, we examined the probability of spiking of CA1 neurons to a range of stimulation voltages using cell-attached recording in the presence of picrotoxin. Despite the decrease in synaptic input to CA1 neurons, no genotypic differences were observed in the output of neurons to electrical stimulation of *str. lacunosum-moleculare* ([Figures 5](#fig5){ref-type="fig"}K and 5L). Furthermore, the spike output of CA1 PCs was not affected when biologically relevant 20-Hz trains of stimuli were delivered to *str. lacunosum-moleculare* ([Figure S5](#mmc1){ref-type="supplementary-material"}). These data show that homeostatic alterations of CA1 PC intrinsic excitability are sufficient to regulate their spiking output.Figure 5Reduced Temporoammonic (TA) Inputs to the CA1 Region(A) Slice recording configuration showing the stimulus electron (Stim) placed in the perforant path, extracellular field electrode (Field) placed in *str. lacunosum-moleculare* (SLM), and the whole-cell patch-clamp electrode (Patch) in *str. pyramidale* (Pyr). Scale bar: 100 μm.(B) Representative extracellular field EPSP (fEPSP, top) and whole-cell EPSP (bottom), recorded in response to increasing voltage stimulation (0--100 V DC), from WT (black) and *Fmr1*^−/y^ (red) mice.(C) Input-output relationship for the afferent fiber volley amplitude in WT (black, 14 slices from 6 mice) and *Fmr1*^−/y^ (red 18 slices from 7 mice) mouse slices. Number of slices indicated.(D and E) fEPSP amplitude (D) and integral (E) recorded in SLM, plotted as a function of afferent fiber volley amplitude from the same slices as above.(F) fEPSP plotted against fiber volley following 50 μM picrotoxin bath application (WT: 12 slices from 5 mice; *Fmr1*^−/y^: 18 slices from 7 mice).(G) Whole-cell patch-clamp recorded EPSP against fiber volley amplitude (WT: 14 cells from 6 mice; *Fmr1*^−/y^: 18 cells from 7 mice).(H) Whole-cell EPSP amplitude in the presence of picrotoxin (WT: 10 cells from 5 mice; *Fmr1*^−/y^: 20 cells from 7 mice).(I) Quantification of the slope of input-output relationships for all EPSPs measured from whole-cell recordings.(J) Representative cell attached recordings from CA1 PCs following stimulation of SLM, overlaid and showing cell spiking for WT (black) and *Fmr1*^−/y^ (red) neurons.(K) Quantification of the percentage of CA1 PCs that responded to TA stimulation with a spike, in cell attached mode, at any stimulation voltage (light shading), compared to those that did not spike (dark shading).(L) Measured spike probability of CA1 PCs at each stimulus strength for WT (black, 26 cells from 7 mice) and *Fmr1*^−/y^ CA1 PCs (red, 30 cells from 9 mice). The number of cells tested is shown in parentheses.^∗^p \< 0.05, from 2-way RM ANOVA (C), sum-of-least-squares F-test (D--H), and GLMM (I). All of the data in (D)--(H) are plotted with linear regression (straight lines). All of the data in the figure are shown as means ± SEMs.

Discussion {#sec3}
==========

Here, we show that hippocampal CA1 PCs are intrinsically hyperexcitable in a mouse model of FXS, likely due to an underlying increase in AIS length. We show that this genotype-specific length change is not due to a lack of plasticity at the AIS, as short-term structural plasticity is present in cultured *Fmr1*^−/y^ neurons. Furthermore, in *ex vivo* tissue, we do not observe a depolarization-induced decrease in AIS length in agreement with previous findings in CA1 ([@bib25]), suggesting the restriction of AIS length changes in intact tissue in the timescales described. Despite the lack of decrease in AIS length (we observe a small but significant increase in AIS length), we do observe a decrease in intrinsic excitability following prolonged depolarization, the magnitude of which is significantly greater in *Fmr1*^−/y^ mice. We also observe reduced entorhinal input to CA1 PCs and in the absence of altered inhibition, suggesting a homeostatic regulation of intrinsic excitability. In support of this activity-dependent homeostatic change in excitability, cell-attached recordings showed no genotypic differences in spike output to entorhinal axon stimulation. In agreement with previous studies, our findings reveal a range of cellular alterations in *Fmr1*^*−*/y^ mice, some of which are likely compensatory or homeostatic, that result in altered circuit function.

Hyperexcitability in the *Fmr1*^*−/y*^ Mouse Model and AIS Length {#sec3.1}
-----------------------------------------------------------------

In the mouse model of FXS, local microcircuits are hyperexcitable ([@bib18]; [@bib27]; [@bib81]). Increased intrinsic neuronal excitability has been observed in hippocampal neurons from CA1 ([@bib48]), CA3 ([@bib22]), and the entorhinal cortex ([@bib21]), as well as from the neocortex ([@bib67]; [@bib81]). The loss of FMRP has been shown to alter cellular excitability through a range of mechanisms. For example, FMRP directly binds to K^+^ channels, and the loss of this interaction alters AP kinetics ([@bib12]; [@bib21]; [@bib22]). Other studies have suggested altered ion channel expression, resulting from homeostatic regulation or altered mRNA translation ([@bib9]; [@bib66]; [@bib81]). In this context, we have also observed a decrease in resting membrane potential in CA1 neurons in the *Fmr1*^*−/y*^ rats. Although difficult to directly relate changes in resting membrane potential in acute slice to neurons *in vivo*, any alteration in resting membrane potential, possibly from an altered K^+^ leak current, would likely contribute to the altered excitability of these neurons. Changes in cellular excitability through subsequent effects on circuit dynamics could explain a range of phenotypes, from altered cognition to increased sensory reactivity and motor dysfunction ([@bib6]; [@bib11]; [@bib52]; [@bib64]). The change in AIS length shown here in *Fmr1*^−/y^ mice constitutes a further potential mechanism contributing to cellular hyperexcitability in hippocampal CA1 pyramidal neurons. The AIS length changes are unlikely related to dendritic complexity ([@bib34]), as AIS location relative to soma was consistent between genotypes. AIS length modulation and increased intrinsic excitability has also been observed in CA1 of the Angelman syndrome mouse model ([@bib39]). This commonality of AIS regulation in another monogenic model of local circuit hyperexcitability suggests a potential convergent mechanism of hyperexcitability between models of autism spectrum disorders and intellectual disability (ASD-ID).

Absence of Short-Term AIS Shortening in *Ex Vivo* Neurons {#sec3.2}
---------------------------------------------------------

In the present study, we confirm that AISs undergo short-term structural plasticity in primary dissociated cell culture following the application of a depolarizing stimuli, as has been shown previously for dentate granule neurons ([@bib25]). This form of plasticity is intact in CA1 *Fmr1*^−*/y*^ neurons, indicating that FMRP is unlikely to play a role in the mechanism by which AIS length is regulated by activity. Furthermore, given that we observed longer AISs in *Fmr1*^−*/y*^ CA1 neurons, *in vivo* and in a more simplified neuronal circuit present *in vitro*, our data suggest that altered AIS length may be a compensatory or homeostatic mechanism used to regulate neuronal excitability in the mouse model of FXS. We did not observe a shortening of the AIS in acute CA1 hippocampal slices from 4- to 5-week-old mice in contrast to cell cultures from other hippocampal cell types. Instead, we observed a small but consistent increase in AIS length in CA1 following KCl treatment. Given that we observed the length changes in cultured neurons from the same mouse colony, we believe that our data cast doubt on the ability of neurons to undergo shortening on the timescales described in cell culture in *ex vivo* tissue. However, it should be noted that we have only tested one time point (i.e., 3 h post-stimulation). It is possible that transient changes in AIS length could be taking place over a shorter time frame, may take longer to manifest, or may be age dependent. Nonetheless, it is clear that the changes in excitability to KCl treatment observed in the present study cannot be explained by changes in AIS length.

Despite an absence of AIS shortening, we did observe a dampening of neuron excitability following 3 h of 15 mM KCl, as shown in the cell culture experiments ([@bib25]) or following longer incubation of KCl ([@bib58]), which also oppose the length changes we observe if the rule of longer AIS equates to increased excitability. Since changes in AIS length cannot explain the changes in excitability, other mechanisms must be involved. One possibility could be altered potassium channel expression or function. Numerous K^+^ channels have been linked to pathophysiology in FXS ([@bib18]; [@bib22]; [@bib81]). The observed slowing of AP decay kinetics is consistent with altered Kv1.1 function ([@bib41]), and the reduction in input resistance we observe could result from increased leak potassium currents ([@bib58]), altered M-channel activity ([@bib78]; [@bib79]; [@bib81]), or altered tonic GABA~A~ receptor activation ([@bib19]). The homeostatic changes in cellular excitability were stronger in *Fmr1*^−/y^ mice, which could result from altered proteostasis ([@bib47]; [@bib65]) or that neuronal spiking in *Fmr1*^−/y^ mice responds more strongly to stimuli on short timescales, thus recruiting ion channels that are typically surplus to the required activity state ([@bib59]). However, it is beyond the scope of the present article to identify the precise mechanism underlying the observed changes in cellular excitability.

It has recently been shown that intrinsic homeostasis is altered in cultured *Fmr1*^−/y^ cortical neurons following reduced activity ([@bib13]), based on neuronal discharge properties not regularly observed in intact brain tissue ([@bib17]). Here, we show that increasing activity results in an exaggerated decrease in neuronal activity in neurons from *Fmr1*^−/y^ mice in *ex vivo* slices. However, consistent with recent findings from the somatosensory cortex ([@bib2]), our finding that CA1 neuronal output is normal despite the decrease in synaptic input from entorhinal cortex suggests that homeostatic mechanisms are able to reset neuronal firing in *Fmr1*^*−/y*^ neurons.

Network-Level Homeostatic Activity in the *Fmr1*^*−/y*^ Mouse {#sec3.3}
-------------------------------------------------------------

Altered long-range connectivity has been proposed as a mechanism for cognitive impairment in FXS and *Fmr1*^−/y^ mice ([@bib32]; [@bib74]; [@bib76]) and *in vitro* ([@bib14]; [@bib35]). Hippocampal function, particularly spatial and episodic memory, has been shown to be deficient in the mouse and rat models of FXS, respectively ([@bib3]; [@bib20]; [@bib71]; [@bib73]); however, most studies have only examined synaptic function and plasticity at specific synapses (i.e., Schaffer collaterals) ([@bib37]). The entorhinal cortex is known to drive spatial inputs to CA1 ([@bib26]; [@bib56]) and forms the TA pathway into the CA1 region ([@bib1]). Therefore, the reduced synaptic input we observe in the *str. lacunosum-moleculare* (co-aligning with TA inputs) may serve as a synaptic correlate of reduced spatial performance in FXS mice. The source of this reduced input could originate in the presynaptic domain ([@bib40]), as entorhinal input to the dentate gyrus is also reduced ([@bib80]). However, presynaptic release properties are not altered at this synapse in *Fmr1*^−/y^ mice ([@bib75]). An alternative explanation for the altered homeostatic plasticity is altered hyperpolarization-activated cyclic nucleotide-gated ion (HCN) channel density or function ([@bib69]), since HCN channels are strongly upregulated in the distal dendrites of CA1 PCs in *Fmr1*^−/y^ mice ([@bib9]). Given the role of HCN channels in reducing dendritic gain ([@bib50]) and enhancing dendritic supralinearity ([@bib10]), it is plausible that increased HCN channel expression is regulated by reduced TA input. HCN channels may be an additional homeostatic element in *Fmr1*^*−*/y^ mice, given that their expression is also bidirectional in different cell types ([@bib8]; [@bib38]).

In summary, we postulate that the increased AIS length and intrinsic excitability in *Fmr1*^−/y^ neurons result from decreased excitation from extrinsic synaptic inputs through altered synaptic strength during development ([@bib8]; [@bib24]; [@bib35]).

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Mouse monoclonal anti-AnkyrinGNeuroMABN106/36; RRID: [AB_10673030](nif-antibody:AB_10673030){#interref65}Rabbit polyclonal anti-AnkyrinGSanta Cruzsc-28561; RRID: [AB_633909](nif-antibody:AB_633909){#interref70}Rabbit polyclonal anti-NeuNMillipore EMDABN78; RRID: [AB_10807945](nif-antibody:AB_10807945){#interref75}Mouse monoclonal anti-NeuNMillipore EMDMAB377; RRID: [AB_2298772](nif-antibody:AB_2298772){#interref80}Alexa 488 goat anti-mouseThermo Fisher ScientificA-11001; RRID: [AB_2534069](nif-antibody:AB_2534069){#interref85}Alexa 568 goat anti-mouseThermo Fisher ScientificA-11004; RRID: [AB_2534072](nif-antibody:AB_2534072){#interref90}Alexa 568 goat anti-rabbitThermo Fisher ScientificA-11011; RRID: [AB_143157](nif-antibody:AB_143157){#interref95}Alexa 633 goat anti-rabbitThermo Fisher ScientificA-21071; RRID: [AB_2535732](nif-antibody:AB_2535732){#interref100}To-Pro 3 IodideThermo Fisher ScientificT3605**Chemicals, Peptides, and Recombinant Proteins**PicrotoxinHellobioHB0506Alexafluor 594 HydrazideThermo Fisher ScientificA10438Vectashield mounting mediumVector LabsH-1400**Experimental Models: Organisms/Strains***Mouse: C57/Bl6J, B6.129P2-Fmr1tm1Cgr/J* (Dutch Belgian Consortium)Jackson Labs003025β1-NaV-GFPNewly generatedN/A**Software and Algorithms**Graphpad Prism 7GraphPad Software<https://www.graphpad.com>R/ R studio[@bib62], [@bib63]<https://www.r-project.org>; <https://rstudio.com>pClampMolecular devices<https://www.moleculardevices.com/products/axon-patch-clamp-system/acquisition-and-analysis-software/pclamp-software-suite#gref>Stimfit[@bib31]<https://github.com/neurodroid/stimfit>ImageJ[@bib68]<https://imagej.net/Fiji/Downloads>NEURON 7.6([@bib15])<https://neuron.yale.edu/neuron/>

Resource Availability {#sec4.2}
---------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Peter C Kind (<pkind@ed.ac.uk>).

### Lead Contact {#sec4.2.1}

Peter C Kind (<pkind@ed.ac.uk>).

### Materials Availability {#sec4.2.2}

All materials will be made available upon reasonable request.

### Data and Code Availability {#sec4.2.3}

All data generated in this study will be made available upon reasonable request.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Mouse models {#sec4.3.1}

All procedures were performed according to Home Office (ASPA, 2013) and The University of Edinburgh Ethical Board. Mice were maintained on a C57/Bl6J background and housed on a 12hr light/dark cycle with *ad libitum* access to food and water. For cell-cultures full litters of male mice were taken at embryonic day 17.5 (E17.5). For 2P imaging experiments, double transgenic mice were bred with β1-NaV-GFP male mice (see below) crossed with *Fmr1*^*+/−*^ mice.

### Dissociated hippocampal culture preparation {#sec4.3.2}

Hippocampal neuronal cell culture were prepared as described previously ([@bib5]). Briefly, hippocampi from embryonic day 17.5 mice were dissected, neurons dissociated in 36000 USP units/ml papain, and then plated on glass-coverslips coated with poly-L-lysine at a density of 1315 cells/mm^2^. Only male mice were selected and a sample of cells from each mouse was kept for later genotyping. Cells were grown in Neurobasal A culture medium supplemented with B-27 (Invitrogen, Carlsbad), 1 mM glutamine, 1% rat serum (Harlan Laboratories) and antibiotic/antimycotic (Life Technologies Ltd). Neurons were treated with mitotic inhibitor Cytosine β-D-arabino-furanoside hydrochloride (4.8 μM) at Div 4 to limit astrocyte proliferation and grown in Neurobasal A media until 10 days *in vitro* (DIV10).

Method Details {#sec4.4}
--------------

### Generation of β1-NaV-GFP mice: {#sec4.4.1}

Transgenic mice expressing the beta1 subunit of the sodium channel (b1-Nav) fused to GFP at the C terminus under the control of the Thy1.2 promoter ([@bib16]) were generated by pronuclear injection. The β1-Na~V~-GFP cDNA ([@bib54]) was cloned into the blunted XhoI site of the pTSC21k vector ([@bib49]), released using Not I as previously described ([@bib82]) and used for pronuclear injection ([@bib70]). Transgenic mice were backcrossed to the C57BL6J/Ola strain. Male b1-Nav-GFP were then backcrossed with female *Fmr1*^+/−^ C57BL6J/Crl mice for at least six generations before data collection.

### Acute slice preparation {#sec4.4.2}

Acute brain slices were prepared similarly to previously described ([@bib7]). Briefly, mice were anesthetised with isofluorane, decapitated and their brain rapidly dissected into ice-cold carbogenated (95 % O2/5 % CO2) sucrose-modified artificial cerebrospinal fluid (ACSF; in mM: 87 NaCl, 2.5 KCl, 25 NaHCO~3~, 1.25 NaH~2~PO~4~, 25 glucose, 75 sucrose, 7 MgCl~2~, 0.5 CaCl~2~). 400 μm brain slices were cut on an oscillating blade vibratome (VT1200S, Leica, Germany). Slices were cut in both the coronal and horizontal planes; in which prelimbic prefrontal cortex (PL-mPFC) or dorsal hippocampus (coronal) and ventro-medial hippocampus (horizontal) were present. Slices were transferred to a submerged chamber in sucrose-ACSF at 35°C for 30 min and then stored at room temperature until needed.

### Whole-cell patch-clamp recordings {#sec4.4.3}

For electrophysiological recordings, slices were transferred to a submerged recording chamber perfused with pre-warmed carbogenated ACSF (in mM: 125 NaCl, 2.5 KCl, 25 NaHCO~3~, 1.25 NaH~2~PO~4~, 25 glucose, 1 MgCl~2~, 2 CaCl~2~) at a flow rate of 4-6 mL.min^-1^ at 31 ± 1°C).Slices were visualized under infrared differential inference contrast microscopy with a digital camera (Orca 2, Hamamatsu, Japan) mounted on an upright microscope (BX61-WI, Olympus, Japan) and a 20x water-immersion objective lens (1.0 N.A., Olympus, Japan). Whole-cell patch-clamp recordings were performed with a Multiclamp 700B (Molecular Devices, CA, USA) amplifier. Recording pipettes were pulled from borosilicate glass capillaries (1.7 mm outer/1mm inner diameter, Harvard Apparatus, UK) on a horizontal electrode puller (P-97, Sutter Instruments, CA, USA). For recordings, pipettes were filled with a K-gluconate based internal solution (in mM 142 K-gluconate, 4 KCl, 0.5 EGTA, 10 HEPES, 2 MgCl~2~, 2 Na~2~ATP, 0.3 Na~2~GTP, 1 Na~2~Phosphocreatine, 2.7 Biocytin, pH = 7.4, 290-310 mOsm), resulting in 3-5 MΩ tip resistance. Cells were rejected if: they were more depolarised than −50 mV, series resistance \> 30 MΩ, or series resistance changed by more than 20% over the course of the recording. For recordings, coronal slices were used to assess baseline intrinsic excitability to match histological findings, while horizontal slices were used for 2-photon imaging, acute plasticity, and temporoammonic stimulation.

Stimulation of the temporoammonic pathway was made with a bipolar twisted Ni:Chrome wire electrode placed in *str. lacunosum-moleculare* at the border of CA1 and subiculum (See [Figure 5](#fig5){ref-type="fig"}A) in slices which CA3 was severed to prevent recurrent activation. Field EPSPs were recorded with a second electrode (patch pipette filled with ACSF) placed in *str. L-M* and a CA1 PC recorded in first cell-attached or whole-cell configurations. Increasing stimuli of 200 μs duration were given to *str. L-M* at 5 or 10 s intervals from constant-voltage stimulation box (Digitimer, Cambridge, UK).

All intrinsic membrane properties were measured in I-clamp. Passive membrane properties, including membrane time constant, input resistance, were measured small hyperpolarising steps (10 pA, 500 ms duration), from resting membrane potential. Active properties were determined from a series of depolarising current steps (0 to +400 pA, 500 ms) from a holding potential of −70mV. All AP properties were determined from the first AP elicited at rheobase. For recordings before 15 mM NaCl or KCl treatment, the intracellular solution included 100 μM AlexaFluor 594 hydrazide (Invitrogen, Dunfermline, UK), which allowed later visual identification of the cell. All recordings were filtered online at 10 kHz with the built-in 4-pole Bessel Filter and digitized at 20 kHz (Digidata1440, Molecular Devices, CA, USA). Traces were recorded in pCLAMP 9 (Molecular Devices, CA, USA) and stored on a personal computer. Analysis of electrophysiological data was performed offline using the open source software package Stimfit ([@bib31]), blind to both genotype and treatment condition.

### 2-photon imaging {#sec4.4.4}

To measure the AIS length in real time, we performed live imaging of β1-NaV-GFP mice. Live imaging was performed on 400 μm thick horizontal, hippocampal slices, as described above. For imaging we used a custom built galvanometric scanning 2-photon microscope (Femto2D-Galvo, Femtonics, Budapest, Hungary) fitted with a tuneable wavelength Ti:Sapphire laser (Chameleon, Coherent, CA, USA), with laser power controlled by a Pockels cell (Conoptics, CT, USA). Signals were detected with photomultiplier tubes through the MES microscope software (Femtonics, Hungary). Following a whole-cell patch-clamp recording being obtained, neurons were dye filled and baseline intrinsic physiology recordings collected. Then a small region of interest (ROI), which comprised the dye filled cell and proximal *str. oriens* of CA1, thus covering the full extent of CA1 PC AIS. Following baseline recordings, a Z stack (1 μm steps) was taken in the top 50 μm of the slice. Then slices were transferred to back to a holding chamber containing recording ACSF with either 15 mM NaCl or 15 mM KCl added 3 h. At the end of the 3 h treatment, slices were then transferred back to the recording chamber and the same ROI (using the filled cell as a landmark) was imaged, under the initial conditions.

### Dissociated hippocampal culture preparation {#sec4.4.5}

Hippocampal neuronal cell culture were prepared as described previously ([@bib5]). Briefly, hippocampi from embryonic day 17.5 mice were dissected, neurons dissociated in 36000 USP units/ml papain, and then plated on glass-coverslips coated with poly-L-lysine at a density of 1315 cells/mm^2^. Only male mice were selected and a sample of cells from each mouse was kept for later genotyping. Cells were grown in Neurobasal A culture medium supplemented with B-27 (Invitrogen, Carlsbad), 1 mM glutamine, 1% rat serum (Harlan Laboratories) and antibiotic/antimycotic (Life Technologies Ltd). Neurons were treated with mitotic inhibitor Cytosine β-D-arabino-furanoside hydrochloride (4.8 μM) at Div 4 to limit astrocyte proliferation and grown in Neurobasal A media until 10 days *in vitro* (DIV10).

### Short term plasticity {#sec4.4.6}

Induction of short term AIS plasticity was performed according to previous studies ([@bib25]; [@bib28]). In dissociated cell-culture, Neurobasal A media was supplemented with 15 mM KCl or NaCl, from 1 M stocks and coverslips returned to the incubator for 3 hours at 37°C. For acute slice plasticity, following recovery at 35°C (as above) slices were transferred to a holding chamber containing recording-ACSF, with 15 mM KCl or NaCl added on top of baseline ionic concentrations. Slices were then incubated for 3h at 35°C, and carbogenated throughout. Following incubation with KCl or NaCl, coverslips or slices were immediately immersion fixed with 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB), pH 7.35 for 20 minutes (coverslips) or 1 hour (slices) at room temperature. For intrinsic physiology plasticity and 2-photon imaging, slices were transferred from the recording chamber into 15 mM KCl or NaCl (as above). After 3 hour incubation, slices were returned to the recording chamber circulating with fresh ACSF and further recordings performed.

### Histological processing and imaging {#sec4.4.7}

For immunohistochemistry, mice were perfusion fixed. Briefly, mice were sedated with isofluorane, followed by terminal anesthesia with sodium pentobarbital (27.5 mg/kg body weight) via intraperitoneal injection. Mice were then transcardially perfused with 20 mL PB with 0.9% saline (PBS), followed by 20 mL of 4% PFA in PB (pH 7.4). The brain was removed and post-fixed in 4% PFA for 1h. 50 μm coronal sections were cut using either an oscillating blade vibratome (VT1000S, Leica, Germany) or a freezing microtome (HM430, Thermo Scientific, UK). Immunocytochemistry was then performed on free floating sections. Sections were washed in PBS, and then blocked for 1 hour at room temperature in 10% normal goat serum (NGS), 0.3% Triton X-100, 0.05% NaN~3~ in PBS. Slices were then incubated in primary antibodies raised against Ankyrin G (mouse, 1:500, clone-N106/36 NeuroMab, UNC Davis, CA, USA) and NeuN (rabbit, 1:500, ABN78, Millipore) diluted in PBS containing 5% NGS, 0.3% Triton X-100 and 0.05% NaN~3~, for 24 to 72 hours at 4°C. Slices were thoroughly washed in PBS, then secondary antibodies (anti-mouse and anti-rabbit AlexaFluor488 and AlexaFluor 568, Invitrogen, UK) applied diluted in PBS containing 3% NGS, 0.1% Triton X-100 and 0.05% NaN3, for 3 hr at room temperature or 24 hr at 4°C. Slices were rinsed in PBS, then PB and mounted on glass slides with Vectashield hard-set mounting medium (H1400, Vector Labs, UK). For cell-culture blocking time was reduced to 10 minutes; primary antibodies incubated over-night at 4°C and secondary antibody incubation for 1 hour at room temperature. Both primary and secondary antibody solutions were identical to those used in slices, but lacking Triton-X.

Confocal image stacks were collected with an AxiovertLSM 510 (Zeiss, Germany) invert scanning-confocal microscope equipped with a 63x (N.A. 1.4, Zeiss, Germany) oil-immersion objective lens. Z stacks (1 μm steps, 1024x1024 pixels) containing ROIs were collected either through the entire 50 μm section (perfusion fixed tissue) or the top 20-30 μm of acute slices. Two stacks of each brain region were collected per experimental condition for each animal. For cell culture experiments, z stacks (1 μm steps, 1024 × 1024 pixels) were taken from the top to bottom of the monolayer of cells and 2 images per coverslip were collected with a 40x (N.A. 1.3, Zeiss, Germany) oil-immersion objective lens.

### Image analysis {#sec4.4.8}

All image analysis was performed with the FIJI package of ImageJ. Based on AnkyrinG or β1-NaV-GFP labeling, AIS were manually traced from their distal tip to either the base of AnkyrinG labeling or the soma (β1-NaV-GFP images) through the 3D image stack using the segmented line tool in FIJI. For fixed tissue, up to 50 AIS were measured for each image, giving a total of up to 100 AIS for each mouse per brain region. For coverslips, 10 to 15 AIS were measured per coverslip. When measuring distance from soma, each AIS was measured, then the distance from the base, to the soma surface measured. For the β1-NaV-GFP labeling validation, 25 AISs per mouse were measured. Independent confirmation of the methodology for AIS measurement was performed by three experimenters, all blind to genotype, and demonstrated a high degree of consistency.

### Computational modeling {#sec4.4.9}

Simulations were performed in NEURON 7.6 software ([@bib15]) using a realistic CA1 pyramidal neuron morphology ([@bib55]). Four additional voltage-dependent currents were added: fast Na^+^ (I~Na~), fast K^+^ (I~Kv~), slow non-inactivating K^+^ (I~Km~) and high voltage activated Ca^2+^ (I~Ca~) and a Ca^2+^ -dependent K^+^ current (I~KCa~) ([@bib51]). Cytoplasmic resistance (R~i~) was set to 150 Ω.cm, membrane capacitance (C~M~) was set to 1 μF/cm^2^ and membrane resistance (R~M~) was set to 30 MΩ.cm^2^. The electrical impact of dendritic spines in realistic neuron morphologies was simulated by doubling dendritic C~M~ and halving dendritic R~M~ ([@bib36]). The axon consisted of a variable length axon initial segment (AIS) followed by twenty 100 μm long segments with low membrane capacitance (C~M~ = 0.1 μF/cm^2^) and high resistance (R~M~ = 150 kΩ.cm^2^) representing myelinated regions, interspersed with 1 μm long Nodes of Ranvier (R~M~ = 50 Ω.cm^2^). Conductance densities (in pS.μm^-2^) were as follows. Dendrites: g~Na~ = 20, g~Ca~ = 0.3, g~KCa~ = 3, and g~Kv~ = 0.1. Soma: as dendrites but g~Kv~ = 200. Axon initial segment: g~Kv~ = 2000, g~Na~ = 30,000. Nodes of Ranvier: g~Na~ = 30,000. Reversal potential for different ionic currents were E~Leak~ = −70 mV, E~K~ = −90 mV, E~Na~ = 60 mV, E~Ca~ = 140 mV). For input resistance changes, R~M~ was scaled uniformly throughout all compartments. Simulations were performed at 40 kHz. 500 ms somatic current steps were applied and the rheobase determined to the nearest 1 pA. AP threshold was classified as the voltage at which the speed of membrane depolarisation first exceeded 20 mV/ms. Simulations were performed at 31°C.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

All experiments were performed blind to genotype, age and treatment (where applicable. Throughout, all data is shown as mean ± SEM. Where applicable, data was analyzed with either a linear mixed-effects model (LMM), or its generalized form (GLMM), whereby the variability due to random effects (animal, slice) was taken into account, allowing for direct measurement of genotype and/or treatment effects. Mixed-effects models were fitted using the Lme4 R package ([@bib4]), where the tested variable is a fixed-effect parameter (i.e., genotype, age or treatment) and random effects (animal, slice) are modeled vectors. All data was tested for normality, with *p-value*s reported as the output of ANOVA tests. Additionally, repeated-measures 2-way ANOVA, with Holm-Sidak post-tests ([Figures 1](#fig1){ref-type="fig"}B, [3](#fig3){ref-type="fig"}C, 3D, and 3H) and Sum-of-least-squares F-tests ([Figures 4](#fig4){ref-type="fig"}D--4H) were employed. For boot-strapping analysis, the proportions of AIS (% of 100 AIS) from the dataset, in an animal dependent manner, were randomly sampled 1000 times and LMM ran on the subsampled data. *P value*s were calculated from these repeated LMM tests and plotted for each percentage of the data sampled and plotted as the x axis. As some animals had \> 95 AIS measured, but not 100, a percentage was used instead of absolute AIS number. Where reported, statistical significance was assumed if p \< 0.05.

Supplemental Information {#app2}
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